Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: FDA

  • National Patient Safety Board Could Be Implemented

    A bill in Congress could create a patient safety board modeled after the successful safety efforts in transportation. The bill would create a National Patient Safety Board that would do for the healthcare industry what the National Transportation Safety Board and Commercial Aviation Safety Team have done to improve safety for those fields for more than 25 years.

  • Reduce Risk of Long COVID Nightmare: Get Vaccinated

    Healthcare workers and millions of other Americans are suffering from the ghost of COVID-19, a seemingly endless or remittent continuation of a disturbing panoply of symptoms that could have been lifted from Dante’s Inferno: cognitive decline, chronic pain, shortness of breath, intense fatigue, and neurological attacks on the body’s organs. This is long COVID, about which there is little consensus on diagnosis, treatment, and prognosis. However, evidence is accumulating suggesting vaccination can prevent or reduce the impact of long COVID.

  • FDA Approves New COVID Vaccine for Fall

    COVID-19 advisors to the FDA voted unanimously to approve a new monovalent vaccine for the coming fall containing the currently predominant omicron subvariant XBB.1.5.

  • FDA’s Final Decision on OTC Birth Control Pill Expected Soon

    The unanimous endorsement of over-the-counter Opill norgestrel tablets by the joint advisory committee of the FDA may put the birth control pill on pharmacy shelves later this year.

  • COVID-19: CMS Ends Vaccine Mandate for HCWs

    The end of the COVID-19 national Public Health Emergency brought a highly controversial issue to a relatively quiet hiatus: Healthcare workers are no longer federally mandated to receive the SARS-CoV-2 vaccine. The Centers for Medicare & Medicaid Services has ended the requirement, which in any case did not apply to boosters or the bivalent vaccines.

  • AOHP Researchers Track Down Needlestick Hazards

    Following an alert from an occupational health manager at a U.S. hospital, researchers with the Association of Occupational Health Professionals in Healthcare found a longstanding sharps injury problem with prefilled syringes that were designed as safety devices.

  • Telehealth and Mail Order Do Not Delay Use of Abortion Medication

    Patients who met with reproductive health providers via telehealth and received medication abortion pills through the mail used the medication in a similar time frame as people who visited clinics in person, according to a recent study.

  • RSV Vaccine for Older Patients Receives Support

    FDA approved Arexvy to protect people age 60 years and older against the respiratory syncytial virus.

  • FDA Panel Greenlights RSV Vaccine for Elderly

    With some concerns and caveats that put a strong emphasis on post-marketing surveillance, vaccine advisors for the Food and Drug Administration have greenlit two vaccines against respiratory syncytial virus infections in people aged 60 years and older.

  • Access to Mifepristone Still in Legal Limbo

    A federal judge may block the use of the safe and effective abortion drug mifepristone after hearing a lawsuit by an anti-abortion organization. The group claimed the FDA had improperly approved mifepristone in 2000.